ICON PLC
ICLR169.190USD
-12.310-6.78%
Handelsschluss 07/31, 16:00（ET）Kurse um 15 Minuten verzögert
13.16BMarktkapitalisierung
17.35KGV TTM
mehr Informationen über ICON PLC Unternehmen
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Unternehmensinformationen
BörsenkürzelICLR
Name des UnternehmensICON PLC
IPO-datumMay 15, 1998
Gegründet am1989
CEODr. Stephen (Steve) Cutler, Ph.D.
Anzahl der mitarbeiter41900
WertpapierartOrdinary Share
GeschäftsjahresendeMay 15
AddresseSouth County Business Park
StadtDUBLIN
BörseNASDAQ Global Select Consolidated
LandIreland
Postleitzahl- -
Telefon35312912000
Websitehttps://www.iconplc.com/
BörsenkürzelICLR
IPO-datumMay 15, 1998
Gegründet am1989
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Anne C. Whitaker
Ms. Anne C. Whitaker
Independent Director
Independent Director
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Ronan Murphy
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Ireland
722.90M
36.12%
United States
671.73M
33.56%
Rest of Europe
374.01M
18.69%
Rest of the World
232.69M
11.63%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Thu, Jul 24
Aktualisiert: Thu, Jul 24
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Artisan Partners Limited Partnership
5.52%
Wellington Management Company, LLP
4.75%
Ninety One UK Limited
3.85%
MFS Investment Management
3.63%
Invesco Advisers, Inc.
3.19%
Other
79.06%
Aktionäre
Aktionäre
Anteil
Artisan Partners Limited Partnership
5.52%
Wellington Management Company, LLP
4.75%
Ninety One UK Limited
3.85%
MFS Investment Management
3.63%
Invesco Advisers, Inc.
3.19%
Other
79.06%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
42.92%
Investment Advisor
35.79%
Hedge Fund
8.82%
Research Firm
2.44%
Pension Fund
2.35%
Bank and Trust
1.47%
Sovereign Wealth Fund
1.29%
Family Office
1.09%
Family Office
1.09%
Other
2.72%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
1327
74.75M
96.11%
-11.06M
2025Q1
1362
81.04M
101.97%
-5.18M
2024Q4
1334
80.88M
97.97%
-5.29M
2024Q3
1290
83.28M
100.86%
-2.02M
2024Q2
1273
83.12M
100.37%
-2.47M
2024Q1
1254
83.08M
100.49%
-3.81M
2023Q4
1237
84.94M
102.98%
-3.00M
2023Q3
1213
86.31M
104.85%
-1.65M
2023Q2
1199
85.95M
104.64%
+2.46M
2023Q1
1190
81.67M
99.73%
-2.49M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Artisan Partners Limited Partnership
4.29M
5.4%
+4.10M
+2097.19%
Mar 31, 2025
Wellington Management Company, LLP
3.69M
4.65%
+1.58M
+74.76%
Mar 31, 2025
Ninety One UK Limited
2.92M
3.67%
-28.77K
-0.98%
Mar 31, 2025
MFS Investment Management
2.83M
3.56%
-61.65K
-2.13%
Mar 31, 2025
Invesco Advisers, Inc.
2.48M
3.12%
+1.10M
+79.31%
Mar 31, 2025
AllianceBernstein L.P.
1.86M
2.34%
+39.46K
+2.17%
Mar 31, 2025
ClearBridge Investments, LLC
1.84M
2.32%
-207.52K
-10.11%
Mar 31, 2025
Templeton Investment Counsel, L.L.C.
1.81M
2.28%
-69.99K
-3.72%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.66M
2.09%
+545.53K
+48.87%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.57M
1.97%
+559.38K
+55.54%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Jul 6
Aktualisiert: Sun, Jul 6
Name
Anteil
iShares MSCI Ireland ETF
4.41%
Polen Capital International Growth ETF
4.14%
VanEck Biotech ETF
2.9%
Polen Capital Global Growth ETF
2.5%
Harbor Health Care ETF
2.27%
Running Oak Efficient Growth ETF
1.72%
Janus Henderson US Sustainable Equity ETF
1.47%
Motley Fool Global Opportunities ETF
1.22%
FPA Global Equity ETF
1.07%
Invesco ESG NASDAQ Next Gen 100 ETF
0.91%
Mehr Anzeigen
iShares MSCI Ireland ETF
Anteil4.41%
Polen Capital International Growth ETF
Anteil4.14%
VanEck Biotech ETF
Anteil2.9%
Polen Capital Global Growth ETF
Anteil2.5%
Harbor Health Care ETF
Anteil2.27%
Running Oak Efficient Growth ETF
Anteil1.72%
Janus Henderson US Sustainable Equity ETF
Anteil1.47%
Motley Fool Global Opportunities ETF
Anteil1.22%
FPA Global Equity ETF
Anteil1.07%
Invesco ESG NASDAQ Next Gen 100 ETF
Anteil0.91%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
